These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18081947)

  • 1. Antibody-based immunotherapy in high-risk neuroblastoma.
    Johnson E; Dean SM; Sondel PM
    Expert Rev Mol Med; 2007 Dec; 9(34):1-21. PubMed ID: 18081947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies in therapy of solid tumors.
    Heimann DM; Weiner LM
    Surg Oncol Clin N Am; 2007 Oct; 16(4):775-92, viii. PubMed ID: 18022544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disialoganglioside directed immunotherapy of neuroblastoma.
    Modak S; Cheung NK
    Cancer Invest; 2007 Feb; 25(1):67-77. PubMed ID: 17364560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells.
    Kowalczyk A; Gil M; Horwacik I; Odrowaz Z; Kozbor D; Rokita H
    Cancer Lett; 2009 Aug; 281(2):171-82. PubMed ID: 19339105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer antibodies.
    Ross JS; Gray K; Gray GS; Worland PJ; Rolfe M
    Am J Clin Pathol; 2003 Apr; 119(4):472-85. PubMed ID: 12710120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-targeted drugs for the therapy of cancer.
    Pietersz GA; Krauer K
    J Drug Target; 1994; 2(3):183-215. PubMed ID: 7812691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroblastoma: Therapeutic strategies for a clinical enigma.
    Modak S; Cheung NK
    Cancer Treat Rev; 2010 Jun; 36(4):307-17. PubMed ID: 20227189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination epigenetic and immunotherapy overcomes resistance to monoclonal antibodies in hematologic malignancies: A new therapeutic approach.
    Epner EM; Saroya BS; Hasanali ZS; Loughran TP
    Exp Hematol; 2016 Mar; 44(3):157-60. PubMed ID: 26802532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of neuroblastoma: present, past and future.
    Raffaghello L; Pistoia V
    Expert Rev Neurother; 2006 Apr; 6(4):509-18. PubMed ID: 16623650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma: monoclonal antibodies-based immunotherapeutic strategies and targeted radiotherapy.
    Chatterjee M; Chakraborty T; Tassone P
    Eur J Cancer; 2006 Jul; 42(11):1640-52. PubMed ID: 16797969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy of poor-prognosis neuroblastoma in children: from bench to bedside].
    Rousseau R; Combaret V; Yvon E; Schell M; Philip I; Puisieux A; Frappaz D; Philip T; Bergeron C
    Bull Cancer; 2006 Feb; 93(2):153-61. PubMed ID: 16517413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in research on monoclonal antibody agents for cancer therapy].
    Zhen Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):9-13. PubMed ID: 12903485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel chimeric anti-NCAM (neural cell adhesion molecule) antibody ch.MK1 displays antitumor activity in SCID mice but does not activate complement-dependent cytolysis (CDC).
    Klehr M; Koehl U; Mühlenhoff M; Tawadros S; Fischer T; Schomäcker K; Heuckmann JM; Bochennek K; Jensen M
    J Immunother; 2009 Jun; 32(5):442-51. PubMed ID: 19609236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy shows promise in Phase III neuroblastoma trial.
    Nat Rev Drug Discov; 2009 Aug; 8(8):604. PubMed ID: 19644467
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody based target tailored antimicrobial chemotherapy - a new approach.
    Singla M
    Med Hypotheses; 2007; 68(5):957-9. PubMed ID: 17141970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies.
    Ducry L; Stump B
    Bioconjug Chem; 2010 Jan; 21(1):5-13. PubMed ID: 19769391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monoclonal antibody therapy: a literature review].
    Del Debbio CB; Tonon LM; Secoli SR
    Rev Gaucha Enferm; 2007 Mar; 28(1):133-42. PubMed ID: 17658067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An overview of antibody therapy against cancer].
    Taniguchi H; Imai K
    Nihon Rinsho; 2012 Dec; 70(12):2087-92. PubMed ID: 23259378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary therapeutic options for children with high risk neuroblastoma.
    Sterba J
    Neoplasma; 2002; 49(3):133-40. PubMed ID: 12097996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant antibody fusion proteins for cancer immunotherapy.
    Reisfeld RA; Gillies SD
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():27-53. PubMed ID: 8815009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.